These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27377395)

  • 1. Adjuvant therapy for highly malignant canine mammary tumours: Cox-2 inhibitor versus chemotherapy: a case-control prospective study.
    Arenas C; Peña L; Granados-Soler JL; Pérez-Alenza MD
    Vet Rec; 2016 Jul; 179(5):125. PubMed ID: 27377395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canine malignant mammary gland neoplasms with advanced clinical staging treated with carboplatin and cyclooxygenase inhibitors.
    Lavalle GE; De Campos CB; Bertagnolli AC; Cassali GD
    In Vivo; 2012; 26(3):375-9. PubMed ID: 22523289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of radiation therapy and firocoxib for the treatment of canine nasal carcinoma.
    Cancedda S; Sabattini S; Bettini G; Leone VF; Laganga P; Rossi F; Terragni R; Gnudi G; Vignoli M
    Vet Radiol Ultrasound; 2015; 56(3):335-43. PubMed ID: 25703137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome and cyclo-oxygenase-2 expression in five dogs with solar dermatitis/actinic keratosis treated with firocoxib.
    Albanese F; Abramo F; Caporali C; Vichi G; Millanta F
    Vet Dermatol; 2013 Dec; 24(6):606-12, e147. PubMed ID: 24128166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of cisplatin versus firocoxib versus cisplatin/firocoxib in dogs with transitional cell carcinoma of the urinary bladder.
    Knapp DW; Henry CJ; Widmer WR; Tan KM; Moore GE; Ramos-Vara JA; Lucroy MD; Greenberg CB; Greene SN; Abbo AH; Hanson PD; Alva R; Bonney PL
    J Vet Intern Med; 2013; 27(1):126-33. PubMed ID: 23205923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical treatment of mammary carcinomas in dogs with or without postoperative chemotherapy.
    Tran CM; Moore AS; Frimberger AE
    Vet Comp Oncol; 2016 Sep; 14(3):252-62. PubMed ID: 24735412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Firocoxib efficacy preventing urate-induced synovitis, pain, and inflammation in dogs.
    Drag M; Kunkle BN; Romano D; Hanson PD
    Vet Ther; 2007; 8(1):41-50. PubMed ID: 17447224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cyclooxygenase inhibitors in a xenograft model of canine mammary tumours.
    Sonzogni-Desautels K; Knapp DW; Sartin E; Doré M
    Vet Comp Oncol; 2011 Sep; 9(3):161-71. PubMed ID: 21848619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant gemcitabine after surgical removal of aggressive malignant mammary tumours in dogs.
    Marconato L; Lorenzo RM; Abramo F; Ratto A; Zini E
    Vet Comp Oncol; 2008 Jun; 6(2):90-101. PubMed ID: 19178668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Cox-2 expression in the prognosis of dogs with malignant mammary tumours.
    Queiroga FL; Pires I; Lobo L; Lopes CS
    Res Vet Sci; 2010 Jun; 88(3):441-5. PubMed ID: 19939424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative adjuvant treatment of invasive malignant mammary gland tumors in dogs with doxorubicin and docetaxel.
    Simon D; Schoenrock D; Baumgärtner W; Nolte I
    J Vet Intern Med; 2006; 20(5):1184-90. PubMed ID: 17063714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of firocoxib and tepoxalin on healing in a canine gastric mucosal injury model.
    Goodman L; Torres B; Punke J; Reynolds L; Speas A; Ellis A; Budsberg S
    J Vet Intern Med; 2009; 23(1):56-62. PubMed ID: 19175721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of ABT-116, an antagonist of transient receptor potential vanilloid type 1, in providing analgesia for dogs with chemically induced synovitis.
    Cathcart CJ; Johnston SA; Reynolds LR; Al-Nadaf S; Budsberg SC
    Am J Vet Res; 2012 Jan; 73(1):19-26. PubMed ID: 22204284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy and safety of firocoxib in the treatment of dogs with osteoarthritis.
    Autefage A; Palissier FM; Asimus E; Pepin-Richard C
    Vet Rec; 2011 Jun; 168(23):617. PubMed ID: 21642297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of firocoxib in the management of canine osteoarthritis under field conditions.
    Hanson PD; Brooks KC; Case J; Conzemius M; Gordon W; Schuessler J; Shelley B; Sifferman R; Drag M; Alva R; Bell L; Romano D; Fleishman C
    Vet Ther; 2006; 7(2):127-40. PubMed ID: 16871495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of firocoxib and carprofen for the treatment of dogs with osteoarthritis.
    Pollmeier M; Toulemonde C; Fleishman C; Hanson PD
    Vet Rec; 2006 Oct; 159(17):547-51. PubMed ID: 17056650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant Thalidomide and Metronomic Chemotherapy for the Treatment of Canine Malignant Mammary Gland Neoplasms.
    DE Campos CB; Lavalle GE; Monteiro LN; Pêgas GRA; Fialho SL; Balabram D; Cassali GD
    In Vivo; 2018; 32(6):1659-1666. PubMed ID: 30348731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effectiveness and safety of a new NSAID, firocoxib: a 1,000 dog study.
    Ryan WG; Moldave K; Carithers D
    Vet Ther; 2006; 7(2):119-26. PubMed ID: 16871494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness of marine based fatty acid compound (PCSO-524) and firocoxib in the treatment of canine osteoarthritis.
    Vijarnsorn M; Kwananocha I; Kashemsant N; Jarudecha T; Lekcharoensuk C; Beale B; Peirone B; Lascelles BDX
    BMC Vet Res; 2019 Oct; 15(1):349. PubMed ID: 31623621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs.
    de Salazar Alcalá AG; Gioda L; Dehman A; Beugnet F
    BMC Vet Res; 2019 Aug; 15(1):309. PubMed ID: 31464629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.